A BILL 
To amend the Employee Retirement Income Security Act 
of 1974 to require a group health plan (or health insur-
ance coverage offered in connection with such a plan) 
to provide for cost sharing for oral anticancer drugs 
on terms no less favorable than the cost sharing provided 
for anticancer medications administered by a health care 
provider. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
22:48 Jul 23, 2021
H4385
2 
•HR 4385 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Cancer Drug Parity 
2
Act of 2021’’. 
3
SEC. 2. PARITY IN COST SHARING FOR ORAL ANTICANCER 
4
DRUGS. 
5
(a) IN GENERAL.—The Employee Retirement Income 
6
Security Act of 1974 is amended by inserting after section 
7
725 of such Act (29 U.S.C. 1185d) the following new sec-
8
tion: 
9
‘‘SEC. 
726. 
PARITY 
IN 
COST 
SHARING 
FOR 
ORAL 
10
ANTICANCER DRUGS. 
11
‘‘(a) IN GENERAL.—Subject to subsection (b), a 
12
group health plan (or health insurance coverage offered 
13
in connection with such a plan) that provides benefits with 
14
respect to anticancer medications administered by a health 
15
care provider shall provide that any cost sharing for pre-
16
scribed, patient-administered anticancer medications that 
17
are used to kill, slow, or prevent the growth of cancerous 
18
cells and that have been approved by the Food and Drug 
19
Administration is no less favorable than the cost sharing 
20
for anticancer medications that is intravenously adminis-
21
tered or injected by a health care provider. 
22
‘‘(b) LIMITATION.—Subsection (a) shall only apply to 
23
an anticancer medication that is prescribed based on a 
24
finding by the treating physician that the medication— 
25
22:48 Jul 23, 2021
H4385
3 
•HR 4385 IH
‘‘(1) is medically necessary for the purpose of 
1
killing, slowing, or preventing the growth of can-
2
cerous cells; or 
3
‘‘(2) is clinically appropriate in terms of type, 
4
frequency, extent site, and duration. 
5
‘‘(c) RESTRICTION ON CERTAIN CHANGES.—A group 
6
health plan (or health insurance coverage offered in con-
7
nection with such a plan) may not, in order to comply with 
8
the requirement of subsection (a), make changes to bene-
9
fits or replace existing benefits with new benefits under 
10
the plan (or health insurance coverage) designed to have 
11
the effect of— 
12
‘‘(1) imposing an increase in out-of-pocket costs 
13
with respect to anticancer medications; 
14
‘‘(2) reclassifying benefits with respect to 
15
anticancer medications in a way that would increase 
16
such costs; or 
17
‘‘(3) applying more restrictive limitations on 
18
prescribed orally administered anticancer medica-
19
tions than on intravenously administered or injected 
20
anticancer medications. 
21
‘‘(d) CONSTRUCTION.—Nothing in this section shall 
22
be construed— 
23
22:48 Jul 23, 2021
H4385
4 
•HR 4385 IH
‘‘(1) to require the use of orally administered 
1
anticancer medications as a replacement for other 
2
anticancer medications; 
3
‘‘(2) to prohibit a group health plan (or health 
4
insurance coverage offered in connection with such a 
5
plan) from requiring prior authorization or imposing 
6
other appropriate utilization controls in approving 
7
coverage for any chemotherapy; or 
8
‘‘(3) to supersede a State law that provides 
9
greater protections with respect to the coverage with 
10
respect to orally administered anticancer medications 
11
than is provided under this section. 
12
‘‘(e) COST SHARING DEFINED.—In this section, the 
13
term ‘cost sharing’ includes a deductible, coinsurance, co-
14
payment, and any maximum limitation on the application 
15
of such a deductible, coinsurance, copayment, and similar 
16
out-of-pocket expenses.’’. 
17
(b) TECHNICAL CORRECTION; CLERICAL CHANGE.— 
18
The table of contents in section 1 of the Employee Retire-
19
ment Income Security Act of 1974 (29 U.S.C. 1001 et 
20
seq.) is amended by inserting after the item relating to 
21
section 725 the following new item: 
22
‘‘Sec. 726. Parity in cost sharing for oral anticancer drugs.’’. 
(c) EFFECTIVE DATE.—The amendments made by 
23
this section shall apply with respect to plan years begin-
24
ning on or after January 1, 2022. 
25
22:48 Jul 23, 2021
H4385
5 
•HR 4385 IH
SEC. 3. GAO STUDY. 
1
Not later than 24 months after the date of the enact-
2
ment of this Act, the Comptroller General of the United 
3
States shall— 
4
(1) complete a study that assesses the impact 
5
of section 726 of the Employee Retirement Income 
6
Security Act of 1974, as added by section 2(a), on 
7
the out-of-pocket costs associated with oral and pa-
8
tient-administered anticancer medications furnished 
9
or dispensed to individuals enrolled in a group 
10
health plan to which such section 726 applies, in 
11
comparison to individuals enrolled in group health 
12
plans or health insurance coverage to which section 
13
726 does not apply, including any recommendations 
14
or matters for congressional consideration regarding 
15
actions Federal agencies or Congress can take to re-
16
duce financial barriers to access to oral and patient- 
17
administered anticancer medications; and 
18
(2) submit to Congress a report on the results 
19
of such study, including recommendations or matters 
20
for congressional consideration to improve access to 
21
oral and patient-administered anticancer medications 
22
for individuals enrolled in group health plans and 
23
group or individual health insurance coverage of-
24
fered by a health insurance issuer. 
25
Æ 
22:48 Jul 23, 2021
H4385
